Skip to main content
. 2023 Dec 20;16(1):29. doi: 10.3390/cancers16010029

Table 1.

Therapeutic Endoscopic Ultrasound (EUS) Indications in Pancreatic Adenocarcinoma.

Disease Complication Therapeutic EUS Considerations Adverse Events Survival Post-Treatment
Biliary obstruction
  • -

    EUS-guided Choledochoduodenostomy

  • -

    EUS-guided Gallbladder Drainage

  • -

    EUS-guided Hepaticogastrostomy
  • -

    Cholangitis (2–7%)

  • -

    Stent misdeployment (2–5%)

  • -

    Stent migration (1–2%)

  • -

    Peritonitis (5%)

  • -

    Bleeding (1%)

 144–232 days (median)
Gastric outlet obstruction EUS-guided Gastroenterostomy
  • -

    Stent misdeployment (0–10%)

  • -

    Peritonitis (1%)

 84–120 days (median)
Afferent Loop Syndrome EUS-guided Enteroenterostomy
  • -

    Stent misdeployment (4–5%)

 110–120 days (median)
Pain EUS-guided celiac plexus neurolysis
  • -

    Diarrhea (1–2%)

  • -

    Fever (1–2%)

  • -

    Transient abdominal pain (5–11%)

 168–314 days (median)

Data obtained from prospective studies described in this manuscript.